News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Raptor Pharmaceutical Inc. (RPTP) Reports Fiscal Year 2012 Financial Highlights and Program Updates



11/1/2012 7:04:59 AM

NOVATO, Calif., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the Company") (Nasdaq:RPTP) today announced its fiscal year 2012 ended August 31, 2012 financial highlights, and updates on its clinical programs including the ongoing extension study of PROCYSBIâ„¢ (cysteamine bitartrate) delayed-release capsules for the potential treatment of patients with nephropathic cystinosis ("cystinosis").

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES